New Marketplace

Survey Snapshot: What Would Accelerate the Adoption of Value-Based Care?

Insights Report · November 27, 2018

Provider revenue from value-based care has been mired at modest levels for some time. In the New Marketplace Survey: Transitioning Payment Models: Fee-for-Service to Value-Based Care, NEJM Catalyst Insights Council members report that value-based reimbursement at their organizations currently stands at 25% of revenue. What single change do they think would accelerate the adoption of value-based care?

Responses to this question are illuminating. According to Frederick Southwick, MD, FACP, CPPS, Director of Patient Care Quality and Safety, Division of Hospitalist Medicine and Professor at the University of Florida in Gainesville, there are complex structural elements in the health care industry that can only be overcome through a government mandate.

“Most institutions are hesitant to embrace value-based care because their systems are inefficient and fail to provide proper feedback,” says Southwick. “Only through mandating this change will value-based care come to pass.”

As a frame of reference, Southwick mentions his “Fixing Healthcare Delivery” course at the University of Florida and Coursera, which examines the potential of applying Lean methodology and the Toyota Production System to health care. He observes that, “Every system is perfectly designed to produce the results it achieves. Our system is presently designed to be wasteful, costly, error prone, and inefficient.”

Paul Manner, MD, a practicing orthopedic surgeon at the UW Medicine Hip and Knee Center at Northwest Primary and Specialty Care, and Professor of Orthopedics and Sports Medicine at the University of Washington School of Medicine in Seattle, says that one of the issues holding back further progress is the absence of a universally accepted definition of value-based care.

“Right now, it’s a convenient term that means whatever the speaker wants it to mean. We’d have as much information if we called it ‘wikalix-based care.’ As in: We urgently need to change from fee-for-service to wikalix-oriented care.”

Along with the need to establish a practical definition of value-based care, Manner says there are other aspects hindering its adoption. “A fundamental problem is that the interests of payers, patients, and providers do not coincide, except in the broadest sense. We can all agree that patients should get the best possible outcome at the lowest cost, but we can’t even agree on how to define ‘cost,’ let alone ‘outcome.’ And that’s not going to change with a single-payer system, by the way.”

Barriers to Implementing Value-Based Reimbursement Models

From the New Marketplace Insights Report: Transitioning Payment Models: Fee-for-Service to Value-Based Care. Click To Enlarge.

Chris DeRienzo, MD, MPP, a practicing neonatal physician and Chief Quality Officer at Mission Health in Asheville, North Carolina, sees the current state of value-based care as a transitional stage in the health care industry’s move to assuming greater risk. He says that only through the adoption of greater risk will value-based participation grow.

“Value-based care is by definition a transitory stop on the journey from fee-for-service to full risk,” says DeRienzo. “The biggest driver by far is market conditions — in markets where payers (public and private) along with employers are willing and able to play, health systems have responded. In markets where health systems have grown into the payer space, the market responded. In markets where either party lacks the will or ability to move to risk, no change in policy or practice will drive change.”

Cautious Optimism That Value-Based Reimbursement Will Become Primary Revenue Model

From the New Marketplace Insights Report: Transitioning Payment Models: Fee-for-Service to Value-Based Care. Click To Enlarge.

Survey respondents express a high level of uncertainty regarding future prospects for value-based care. Manner says he believes that value-based care will be the primary revenue model, particularly given the federal government’s increasing commitment to value-based programs. However, he says that providers will respond to these programs in a variety of ways.

“In the joint replacement world, we see bundled care, which includes a carrot and stick approach from the federal government. The carrot is slightly higher reimbursement if you hit certain targets; the stick is the fact that your organization is responsible for all costs. So as a provider, you have a few options. One is to comply vigorously and work at cost containment, no matter what. Another is to cherry-pick and lemon-drop — you keep the healthy, engaged patients in your system, and send the sicker, less advantaged patients elsewhere. My expectation, frankly, is that patients with government insurance (Medicare, but especially Medicaid), will be covered under value-based care plans, and the providers taking care of them will be working harder for less.”

Ultimately, DeRienzo sees some form of value-based reimbursement as the primary model for the industry, although he believes that the industry is in the middle of an evolutionary process that will end up with a population health model.

“We’re currently in the middle ground,” he says. “Some folks refer to it as having a foot in two canoes, but I like to think of it as being on the platform of a catamaran and we are moving from one hull to the other.”

“I think the most mature version of the model will be moving to true population health–based payment mechanisms — for example, Medicare Advantage plans, full-risk ACOs, and bundles, in part because federal payers are demanding predictability in spend. And one way for CMS to have predictability in spend is to transfer that risk onto someone else. So, what we are seeing is really a spectrum of being drawn into the population risk space.”

Interestingly, when asked about their organizations’ value-based care status, 51% of respondents reported that they either already are or expect to be providing value-based care in 3 years. This finding indicates that, while respondents are uncertain as to whether value-based care will ever be the primary revenue model, they still believe that it will be part of the reimbursement landscape in one form or another.

DeRienzo points out that many providers are already there, given that value-based care rates can vary quite widely depending on the definition being used, geography, and the number of Medicare and Medicaid patients an organization has.

“I think that number is representative of the variability across the United States. If you’re in Utah, you are already there. If you’re in Danville, Pennsylvania, you’re definitely already there. In other parts of the country, they are still catching up. Certainly, anybody playing in the CMS space is already there. Outside of CMS, over the next 10 years most of America is going to be in some kind of value-based care arrangement.”

New call for submissions ­to NEJM Catalyst

Now inviting longform articles


A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »

More From New Marketplace
Elements of a Sustainable Complex Care Management Contract

Sustainable Financing for Complex Care Management Is Critical to a Value-Driven Health Care System

Care management should be payer-agnostic at its core.

Comparison of Certain Model Features in Blue Cross NC Blue Premier vs Next-Generation ACO Model vs BCBSMA Alternative Quality Contract

Engineering a Rapid Shift to Value-Based Payment in North Carolina: Goals and Challenges for a Commercial ACO Program

We believe North Carolina can be a model for the nation.

Small Molecule Drugs Facing Generic Competition - Orphan and Non-Orphan Drugs - Orphan Drug Act

It’s Time to Reform the Orphan Drug Act

Three proposals for improving the law to reflect 21st-century drug development practices.

Three-Part Pricing of PCSK9 Inhibitors

A New Model for Pricing Drugs of Uncertain Efficacy

Are we paying too much for new drugs before we know how well they work? This innovative pricing model proposes postponing major rewards until efficacy is established — which could help both patients and payers while still paying back investments on the most effective drugs.

what does quality measurement in health care mean

Buzz Survey Report: Addressing the Problems of Quality Measurement

An independent NEJM Catalyst report sponsored by University of Utah Health on patient involvement in quality measurement.

Average HOOS and Average KOOS for patients undergoing hip and knee replacement at CJRI

Building a “Hospital-within-Hospital” Model for Joint Replacements

The Connecticut Joint Replacement Institute has demonstrated that formerly competing independent providers can unite on a common vision to yield drastic improvements in quality, safety, and costs.

Discharge Rates and Follow-Up Internval Dashboard for One Provider at MGH Dermatology

A Successful Pilot to Improve Access by Adjusting Discharge and Follow-Up Rates

Actionable data and modest financial incentives can help motivate clinicians to adjust their behavior around scheduling follow-up appointments.

Strongwater08_pullquote primary care value proposition and disruptive innovation

The Evolution of Primary Care: Embracing Innovation While Protecting the Core Value

Primary care must leverage disruptive innovations to ensure that patients receive first-access, comprehensive, coordinated, continuous care that is woven into a seamlessly integrated system.

Berns01_pullquote nephrologists dialysis facility joint venture conflicts of interest

Dialysis-Facility Joint-Venture Ownership — Hidden Conflicts of Interest

Despite potential benefits, joint ventures between nephrologists and dialysis companies raise legal and ethical concerns because of participants’ conflicts of interest and lack of transparency.

Fee-for-Service Continues to Account for the Majority of Revenue

New Marketplace Survey: Transitioning Payment Models: Fee-for-Service to Value-Based Care

In a survey of the NEJM Catalyst Insights Council sponsored by Optum, respondents express enthusiasm for value-based care but have conflicting opinions about just how far along that path they should go.


A weekly email newsletter featuring the latest actionable ideas and practical innovations from NEJM Catalyst.

Learn More »


Value Based Care

199 Articles

Curbing Health Care Spending: The Provider’s…

Health care costs have historically grown at about 2% faster than income in the United…

Medicare and Medicaid

122 Articles

A Collaborative Model to Expand Medicaid…

How managing the benefit coverage expansion for the treatment of HCV in New Mexico was…

Vertical Integration and Bold Experimentation

Four points on improving value in health care via vertical integration and aggressive experimentation.

Insights Council

Have a voice. Join other health care leaders effecting change, shaping tomorrow.

Apply Now